Clinical Trial

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Study acronym: ASCENDE-SBRT
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is being done to answer the following question: Is the strategy to give higher doses of radiotherapy treatment over a shorter period of time using special equipment and fewer treatments (also known as Stereotactic Body Radiation Therapy or SBRT) as effective as usual external radiation therapy given with a brachytherapy boost (which involves radiation sources inserted directly into the prostate)?
Protocol Amendment History 1 change
notable Trial sites expanded: 53 -> 57 locations 2026-04-15
Trial Details
NCT Number NCT06235697
Lead Sponsor Canadian Cancer Trials Group
Collaborators: NRG Oncology
Conditions Prostate Cancer
Enrollment 710 participants
Start Date 2024-04-25
Primary Completion 2032-10-31 (estimated)
Study Completion 2033-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14